Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease

Journal of Neurochemistry

Volumn 98, Issue 4, 2006, Pages 1090-1099

  Mormone, Elisabetta ^a,b   Matarrese, Paola ^a   Tinari, Antonella ^a   Cannella, Milena ^c   Maglione, Vittorio ^c   Farrace, Maria Grazia ^b   Piacentini, Mauro ^b   Frati, Luigi ^d   Malorni, Walter ^a   Squitieri, Ferdinando ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS NEUROMED   (Italy)

^d NONE

Author keywords

Apoptosis; Autophagy; Huntington's disease; Lymphoblasts; Mitochondria

Indexed keywords

APOPTOSIS; ARTICLE; AUTOPHAGY; CANNIBALISM; CELL ACTIVATION; CELL ACTIVITY; CELL DEATH; CELL IMMORTALIZATION; CELL LINE; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; HYPERPOLARIZATION; LYMPHOBLAST; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; PATHOGENICITY; PATIENT; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ANNEXIN A5; CELL DEATH; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HUNTINGTON DISEASE; LYMPHOCYTES; MEMBRANE POTENTIALS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; PHAGOCYTOSIS;

EID: 33746394263     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03998.x     Document Type: Article

References (30)

1. Boya P., Gonzalez-Polo R. A., Casares N. et al. (2005) Inhibition of macroautophagy triggers apoptosis. Mol. Cell Biol. 25, 1025-1040.
2. Browne S. E., Bowling A. C., MacGarvey U., Baik M. J., Berger S. C., Muqit M. M., Bird E. D. and Beal M. F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
3. Codogno P. and Meijer A. J. (2005) Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12, 1509-1518.
4. Cuervo A. M. (2004) Autophagy: many paths to the same end. Mol. Cell Biochem. 263, 55-72.
5. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P. and Aronin N. (1997) Aggregation of huntington in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science 277, 1990-1993.
6. Elmore S. P., Quian T., Grissom S. F. and Lamaster J. J. (2002) The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J. 15, 2286-2287.
7. Eskelinen E. L. (2005) Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ. 12, 1468-1472.
8. Gordon S. (1999) Macrophage-restricted molecules: role in differentiation and activation. Immunol. Lett. 65, 5-8.
9. Gozuacik D. and Kimchi A. (2004) Autophagy as a cell death and tumor suppressor machanism. Oncogene 23, 2891-2906.
10. Gross A., Pilcher K., Blachly-Dyson E., Basso E., Jockel J., Bassik M. C., Korsmeyer S. J. and Forte M. (2000) Biochemical and genetic analysis of the mitochondrial response of yeast to BAX and BCL-X(L). Mol. Cell Biol. 20, 3125-3136.
11. Iwata A., Riley B. E., Johnston J. A. and Kopito R. R. (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated Huntingtin. J. Biol. Chem. 280, 40 282-40 292.
12. Klionsky D. J. (2004) Cell biology: regulated self-cannibalism. Nature 431, 31-32.
13. Kroemer G. and Jaattela M. (2005) Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 5, 886-897.
14. Kroemer G. and Reed J. C. (2000) Mitochondrial control of cell death. Nat. Med. 6, 513-519.
15. Kroemer G., El-Deiry W. S., Golstein P. et al. (2005) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 12, 1463-1467.
16. Li S. H. and Li X. J. (2004) Huntingtin and its role in neuronal degeneration. Neuroscientist 10, 467-475.
17. Maglione V., Cannella M., Gradini R., Cislaghi G. and Squitieri F. (2006) Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation. Mech. Ageing Dev. 127, 213-216.
18. Matarrese P., Gambardella L., Cassone A., Vella S., Cauda R. and Malorni W. (2003) Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors. J. Immunol. 170, 6006-6015.
19. Matarrese P., Tinari A., Gambardella L., Mormone E., Narilli P., Pierdominici M., Cauda R. and Malorni W. (2005) HIV protease inhibitors prevent mitochondrial hyperpolarization and redox imbalance and decrease endogenous uncoupler protein-2 expression in gp 120-activated human T lymphocytes. Antivir. Ther. 10, M29-M45.
20. Milakovic T. and Johnson G. V. (2005) Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. J. Biol. Chem. 280, 30 773-30 782.
21. Nagata E., Sw A., Ross C. A. and Snyder S. H. (2004) Autophagosome-like vacuole formation in Huntington's disease lymphoblasts. Mol. Neurosci. 15, 1325-1328.
22. Panov A. V., Gutekunst C. A., Leavitt B. R., Hayden M. R., Burke J. R., Strittmatter W. J. and Greenamyre J. T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct affect of polyglutamines. Nat. Neurosci. 5, 731-736.
23. Penno M. B., Pedrotti-Krueger M. and Ray T. (1993) Cryopreservation of whole blood and isolated lymphocytes for B-cell immortaliza-tion. J. Tissue Cult. Meth. 15, 43-48.
24. Perl A., Gergely P., Jr, Nagy G., Koncz A. and Banki K. (2004) Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 25, 360-367.
25. Rodriguez-Enriquez S., He L. and Lamasters J. H. (2004) Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int. J. Biochem. Cell Biol. 36, 2463-2472.
26. Sawa A. (2001) Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria? J. Mol. Med. 79, 375-381.
27. Sawa A., Wiegand G. W., Cooper J., Margolis R. L., Sharp A. H., Lawler J. F., Jr, Greenamyre J. T., Snyder S. H. and Ross C. A. (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat. Med. 5, 1194-1198.
28. Squitieri F., Gellera C., Cannella M. et al. (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126, 946-955.
29. Tarr J. and Eggleton P. (2005) Immune function of C1q and its modulators CD91 and CD93. Crit. Rev. Immunol. 25, 305-330.
30. Yu Z. X., Li S. H., Evans J., Pillarisetti A., Li H. and Li X. J. (2003) Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J. Neurosci. 23, 2193-2202.